Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.128%)
Open: 40.00
High: 40.00
Low: 40.00
Prev. Close: 40.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New advisory client, Vertequip

9 Mar 2015 07:00

RNS Number : 7807G
Frontier IP Group plc
09 March 2015
 



 

 

AIM: FIPP

Frontier IP Group plc

("Frontier IP" or "the Company")

 

New Advisory Client - Vertequip

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has been engaged to provide advisory and business development services to VERTEQUIP - Equipamentos e trabalhos verticais, LDA ("Vertequip").

Vertequip, a Portuguese company, was formed to develop and exploit a new technology, STEP (http://site.vertequip.com/products), which allows the service and maintenance of high vertical structures to be performed in a safer, faster and more cost-effective way. Vertequip is targeting the renewable energy, construction, offshore oil & gas and relevant industrial markets. Current customers include utilities and energy companies, who respectively use Vertequip solutions in wind turbines and dams, and for the maintenance of offshore oil rigs.

Frontier IP will assist Vertequip in further exploiting the commercial potential of its technology and to accelerate the expansion of its sales into new and existing markets.

Neil Crabb, Chief Executive of Frontier IP, said,

"This collaboration with Vertequip represents an exciting opportunity for Frontier IP in the energy market. Our strategy to focus on energy as one of our key sectors is progressing well, as we expand our resource and build connections to a network of market players such as EDP and Iberdrola, two major utilities. We look forward to working with Vertequip to maximise the potential of its innovative technology and product range."

Pedro Goncalves, Chief Operating Officer of Vertequip, said,

"We are delighted to enter into this agreement and get the support of Frontier IP on the commercialisation of our innovative products."

 

Enquiries

 

Frontier IP Group Plc

0131 240 1251

 

Neil Crabb, Chief Executive

 

Company website: www.frontierip.co.uk

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

 

Mark Percy / Catherine Leftley, Corporate Finance

 

David Banks, Corporate Broking

 

 

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

 

Lucy Williams

 

 

KTZ Communications

020 3178 6378

 

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

 www.frontierip.co.uk.

 

Vertequip - Equipamentos e trabalhos verticais, LDA

Vertequip specialises in the production of service and maintenance equipment for high vertical structures, including oil rigs, wind turbines, mines and construction sites. Its principal product, STEP, is designed to increase safety and enhance productivity when working at considerable heights.

 

Vertiquip is based in Portugal, with distributors selling its products across Europe, Africa, the Middle East and South America.

http://site.vertequip.com/products

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKMGGFMVKGKZM
Date   Source Headline
9th Dec 20197:00 amRNSGrant of Options
6th Dec 20196:25 pmRNSHolding(s) in Company
5th Dec 201912:00 pmRNSHolding(s) in Company
4th Dec 201912:00 pmRNSResult of AGM & Total Voting Rights
26th Nov 201912:58 pmRNSHolding(s) in Company
13th Nov 20195:00 pmRNSPosting of Annual Report and Accounts
7th Nov 201912:20 pmRNSHolding(s) in Company
6th Nov 20192:00 pmRNSResult of Placing
6th Nov 20197:01 amRNSProposed fundraising of £3.5m by way of Placing
6th Nov 20197:00 amRNSFinal Results
22nd Oct 20197:00 amRNSAppointment of senior advisers
15th Oct 20197:00 amRNSNew portfolio company: Elute Intelligence Holdings
10th Sep 20197:00 amRNSAppointment of Broker
25th Jul 20197:00 amRNSExscientia collaboration with Rallybio
15th Jul 201912:08 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSExscientia partnership with GT Apeiron
31st May 20195:00 pmRNSTotal Voting Rights
31st May 20193:15 pmRNSDirectorate Change
28th May 20197:00 amRNSFieldwork Robotics completes initial field trials
15th May 20197:00 amRNSDirector exercise of options, shareholding and TVR
10th May 201911:48 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSEuropean plan to boost marine & coastal economies
8th Apr 20197:00 amRNSParkside Architectural Tiles launch Alusid range
8th Apr 20197:00 amRNSBosch UK to work with Pulsiv Solar
8th Apr 20197:00 amRNSInvestor event at the Royal Academy of Engineering
4th Apr 20197:00 amRNSExscientia reaches first major milestone with GSK
3rd Apr 20195:51 pmRNSHolding(s) in Company
3rd Apr 20193:45 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSFieldwork Robotics wins Innovate UK ISCF grant
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSBoard Appointment
27th Mar 20197:00 amRNSUnaudited Half Year Results
21st Mar 20199:18 amRNSTrading Update
21st Mar 20199:14 amRNSExscientia & Celgene drug discovery collaboration
6th Mar 20195:15 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNSTVG - key partner in $9.67m DARPA project award
12th Feb 20197:00 amRNSThird Portuguese spin out: Insignals Neurotech
4th Feb 20197:00 amRNSAmprologix wins DHSC backing for new antibiotic
31st Jan 20199:00 amRNSNandi Proteins led consortium wins UK grant
25th Jan 20197:00 amRNSThe Vaccine Group wins Department of Health grant
7th Jan 20191:29 pmRNSExscientia Series B funding & Roche collaboration
27th Dec 20187:00 amRNSMolendotech - Palintest start commercial roll out
19th Dec 201811:45 amRNSResult of AGM
30th Nov 20185:30 pmRNSTotal Voting Rights
23rd Nov 201812:10 pmRNSPosting of Annual Report and Notice of AGM
22nd Nov 20181:12 pmRNSHolding(s) in Company
22nd Nov 201810:36 amRNSHolding(s) in Company
21st Nov 20183:30 pmRNSHolding(s) in Company
21st Nov 201811:00 amRNSTotal Voting Rights and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.